TY - JOUR
T1 - Cardiovascular Disease and Breast Cancer
T2 - Where These Entities Intersect: A Scientific Statement From the American Heart Association
AU - American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research
AU - Mehta, Laxmi S.
AU - Watson, Karol E.
AU - Barac, Ana
AU - Beckie, Theresa M.
AU - Bittner, Vera
AU - Cruz-Flores, Salvador
AU - Dent, Susan
AU - Kondapalli, Lavanya
AU - Ky, Bonnie
AU - Okwuosa, Tochukwu
AU - Piña, Ileana L.
AU - Volgman, Annabelle Santos
N1 - Publisher Copyright:
© 2018 American Heart Association, Inc.
PY - 2018/2/20
Y1 - 2018/2/20
N2 - Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many people perceive breast cancer to be the number one threat to women's health. CVD and breast cancer have several overlapping risk factors, such as obesity and smoking. Additionally, current breast cancer treatments can have a negative impact on cardiovascular health (eg, left ventricular dysfunction, accelerated CVD), and for women with pre-existing CVD, this might influence cancer treatment decisions by both the patient and the provider. Improvements in early detection and treatment of breast cancer have led to an increasing number of breast cancer survivors who are at risk of long-term cardiac complications from cancer treatments. For older women, CVD poses a greater mortality threat than breast cancer itself. This is the first scientific statement from the American Heart Association on CVD and breast cancer. This document will provide a comprehensive overview of the prevalence of these diseases, shared risk factors, the cardiotoxic effects of therapy, and the prevention and treatment of CVD in breast cancer patients.
AB - Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many people perceive breast cancer to be the number one threat to women's health. CVD and breast cancer have several overlapping risk factors, such as obesity and smoking. Additionally, current breast cancer treatments can have a negative impact on cardiovascular health (eg, left ventricular dysfunction, accelerated CVD), and for women with pre-existing CVD, this might influence cancer treatment decisions by both the patient and the provider. Improvements in early detection and treatment of breast cancer have led to an increasing number of breast cancer survivors who are at risk of long-term cardiac complications from cancer treatments. For older women, CVD poses a greater mortality threat than breast cancer itself. This is the first scientific statement from the American Heart Association on CVD and breast cancer. This document will provide a comprehensive overview of the prevalence of these diseases, shared risk factors, the cardiotoxic effects of therapy, and the prevention and treatment of CVD in breast cancer patients.
KW - AHA Scientific Statement
KW - breast cancer
KW - cardiotoxicity
KW - cardiovascular disease
KW - oncology
KW - prevention
KW - risk factors
UR - http://www.scopus.com/inward/record.url?scp=85063972825&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063972825&partnerID=8YFLogxK
U2 - 10.1161/CIR.0000000000000556
DO - 10.1161/CIR.0000000000000556
M3 - Article
C2 - 29437116
AN - SCOPUS:85063972825
SN - 0009-7322
VL - 137
SP - e30-e66
JO - Circulation
JF - Circulation
IS - 8
ER -